πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 28 of 78

  1. US 9850468

    Infectious hepatitis E virus genotype 3 recombinants

    Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9845350

    Monoclonal antibodies that react with the capsule of bacillus anthracis

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9844569

    Methods of producing enriched populations of tumor reactive T cells from peripheral blood

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9833468

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9833519

    Methods for the diagnosis and treatment of sjΓΆgren's syndrome

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9833437

    Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9827223

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9822162

    Anti-human papillomavirus 16 E6 T cell receptors

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9821029

    Methods of reducing salmonella in poultry

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9822057

    Solid forms of treprostinil

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9820965

    Biologically active macrolides, compositions, and uses thereof

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9814771

    Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9815887

    Monoclonal antibodies that neutralize a norovirus

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9809824

    CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9809643

    Identification of antibodies specific for at least two different lyssaviruses

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9808520

    Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9803022

    Mesothelin domain-specific monoclonal antibodies and use thereof

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9802904

    Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9801865

    Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9804163

    Biomarkers for prostate cancer and methods for their detection

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9795661

    TH1/TH2 polarizing vaccines

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9795662

    Vaccine comprising AMA1 and RON2

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9795665

    Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9789162

    Systemic and local ex vivo gene therapy of the skeleton

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9790261

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9790473

    Human Ebola virus species and compositions and methods thereof

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9783590

    Variants of human taste receptor genes

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9783579

    Compositions and methods for dengue virus chimeric constructs in vaccines

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9783596

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9782399

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9782465

    Serologic correlates of protection against Bacillus anthracis infection

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9783595

    Neutralizing GP41 antibodies and their use

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9775895

    HIV therapeutics and methods of making and using same

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9770405

    Biocompatible capsules and methods of making

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9771428

    CD47 targeted therapies for the treatment of infectious disease

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9765142

    TEM8 antibodies and their use in treatment and detection of tumors

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9763444

    Compositions and methods for repelling blood-sucking and biting insects, ticks and mites

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9765123

    Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9765342

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9765031

    Cannabinoid receptor mediating compounds

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9765063

    Amido compounds as RORΞ³t modulators and uses thereof

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9765047

    Process for making beraprost

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9764022

    Methods and compositions for inhibiting polyomavirus-associated pathology

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9757425

    Method and composition for synchronizing time of insemination

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9758465

    Controlled release pharmaceutical formulations

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.